Affiliation:
1. Department of Nephrology, Faculty of Medical Sciences, University of Fukui
2. Headquarters for Innovative Society-Academia Cooperation, University of Fukui, Fukui, Japan.
Abstract
Pediatric dialysis requires low flow from the body, but greater flow is needed to prevent clogging. As a solution, we developed a new continuous hemodiafiltration system with blood recirculation (CHDF-R), which enables separate settings for blood flow from the body and to the hemofilter. We compared CHDF-R with conventional continuous hemodiafiltration (CHDF) of bovine plasma and blood by monitoring the transmembrane pressure (TMP) and observing the hemofilter membrane surface. When using bovine plasma, the postdialysis TMP with CHDF-R was significantly lower than with CHDF (median CHDF, 23.7; median CHDF-R, 18.1; p = 0.029). Likewise, when using bovine blood, the postdialysis TMP was also significantly lower with CHDF-R than with CHDF (median CHDF, 150; median CHDF-R, 100; p = 0.029). Moreover, the area of clogged membrane was significantly smaller with CHDF-R than with CHDF, and the inner membrane surface showed less material deposition with CHDF-R than CHDF. CHDF-R thus appears to suppress accumulation of clogging substances by producing higher shear stress within hollow fiber membranes.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Biomedical Engineering,General Medicine,Biomaterials,Bioengineering,Biophysics
Reference19 articles.
1. KDIGO clinical practice guidelines for acute kidney injury.;Khwaja;Nephron Clin Pract,2012
2. Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.;Ferguson;Am J Med Sci,2013
3. Dialysis filter life, anticoagulation, and inflammation in COVID-19 and acute kidney injury.;Wen;Kidney360,2020
4. Coagulation and sepsis.;Levi;Thromb Res,2017
5. Continuous renal replacement therapy: Who, when, why, and How.;Tandukar;Chest,2019